These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 8457271)
1. Immunization of preterm infants. Peter G Pediatrics; 1993 Jan; 91(1):168-9. PubMed ID: 8457271 [No Abstract] [Full Text] [Related]
2. Tolerance of initial diphtheria-tetanus-pertussis immunization in preterm infants. Topsis J; Kandall S; Weinstein J; Wilets I J Perinatol; 1996; 16(2 Pt 1):98-102. PubMed ID: 8732555 [TBL] [Abstract][Full Text] [Related]
3. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine. Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903 [TBL] [Abstract][Full Text] [Related]
4. Primary care physicians' knowledge about diphtheria-tetanus-pertussis immunizations in preterm infants. Langkamp DL; Langhough R Pediatrics; 1992 Jan; 89(1):52-5. PubMed ID: 1728022 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population. Batra JS; Eriksen EM; Zangwill KM; Lee M; Marcy SM; Ward JI; Pediatrics; 2009 Mar; 123(3):951-8. PubMed ID: 19255025 [TBL] [Abstract][Full Text] [Related]
6. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851 [TBL] [Abstract][Full Text] [Related]
7. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Romero A; Lopez G; Dal-Ré R Pediatrics; 2005 Dec; 116(6):1292-8. PubMed ID: 16322149 [TBL] [Abstract][Full Text] [Related]
8. Immunisation of preterm babies. Moyes C N Z Med J; 1999 Jul; 112(1092):263-4. PubMed ID: 10472887 [No Abstract] [Full Text] [Related]
9. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Vázquez L; Garcia F; Rüttimann R; Coconier G; Jacquet JM; Schuerman L Acta Paediatr; 2008 Sep; 97(9):1243-9. PubMed ID: 18489623 [TBL] [Abstract][Full Text] [Related]
13. FDA approval of a fourth acellular pertussis vaccine for use among infants and young children. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(43):934-6. PubMed ID: 9822368 [TBL] [Abstract][Full Text] [Related]
14. [Seroconversion after vaccination against pertussis, Haemophilus influenzae type b and poliomyelitis in preterm infants]. Sikora JP; Chlebna-Sokół D Przegl Lek; 2003; 60(11):699-703. PubMed ID: 15058036 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine. Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088 [TBL] [Abstract][Full Text] [Related]
17. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
18. Safety of DTaP-IPV-HIb-HBV hexavalent vaccine in very premature infants. Faldella G; Galletti S; Corvaglia L; Ancora G; Alessandroni R Vaccine; 2007 Jan; 25(6):1036-42. PubMed ID: 17088013 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [TBL] [Abstract][Full Text] [Related]
20. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]